Nephros, Inc.NEPHNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank85
5Y CAGR+52.6%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
+52.6%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
8.3x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 132.32% |
| Q3 2025 | -90.04% |
| Q2 2025 | 208.70% |
| Q1 2025 | -75.31% |
| Q4 2024 | 309.31% |
| Q3 2024 | -24.35% |
| Q2 2024 | 25.45% |
| Q1 2024 | -183.54% |
| Q4 2023 | -142.17% |
| Q3 2023 | 148.67% |
| Q2 2023 | -18.12% |
| Q1 2023 | 241.54% |
| Q4 2022 | -14.71% |
| Q3 2022 | 84.14% |
| Q2 2022 | 40.35% |
| Q1 2022 | -436.42% |
| Q4 2021 | 63.19% |
| Q3 2021 | -677.78% |
| Q2 2021 | -112.73% |
| Q1 2021 | 96.40% |
| Q4 2020 | 16.02% |
| Q3 2020 | -5.64% |
| Q2 2020 | 6.52% |
| Q1 2020 | -605.49% |
| Q4 2019 | 159.28% |
| Q3 2019 | 53.80% |
| Q2 2019 | -90.67% |
| Q1 2019 | -32.01% |
| Q4 2018 | 52.94% |
| Q3 2018 | 16.46% |
| Q2 2018 | -100.75% |
| Q1 2018 | -137.29% |
| Q4 2017 | 351.61% |
| Q3 2017 | -42.89% |
| Q2 2017 | 24.28% |
| Q1 2017 | -24.81% |
| Q4 2016 | 33.16% |
| Q3 2016 | -190.44% |
| Q2 2016 | 47.89% |
| Q1 2016 | 57.90% |